Výsledky vyhledávání - "HIV Protease Inhibitors/adverse effects/therapeutic use"

Long-term safety and effectiveness of lopinavir/ritonavir in antiretroviral-experienced HIV-1-infected children

Autor: Rudin, Christoph, Wolbers, Marcel, Nadal, David, Rickenbach, Martin, Bucher, Heiner C, the Pediatric Infectious Disease Group of Switzerland (PIGS), the Swiss Mother and Child HIV Cohort Study (MoCHiV)

Publikováno v: Archives of Disease in Childhood, Vol. 95, No 6 (2010) pp. 478-81

AIM: To evaluate the long-term safety and effectiveness of lopinavir/ritonavir (LPV/r) in a population-based cohort of HIV-1-infected children. METHODS: All children enrolled in the Swiss Mother and Child HIV Cohort Study, treated with LPV/r-based co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05fc413a7b44baad66da346e3eb97c77
https://doi.org/10.1136/adc.2009.169375

Zobrazit plný text záznamu

Switching from protease inhibitors to efavirenz: differences in efficacy and tolerance among risk groups: a case–control study from the Swiss HIV Cohort

Autor: Bernard Hirschel, Heiner C. Bucher, Thomas Wagels, Markus Flepp, Amalio Telenti, Enos Bernasconi, Bruno Ledergerber, Claudine Zellweger

Publikováno v: AIDS, Vol. 16, No 3 (2002) pp. 381-385

OBJECTIVES: Many patients have simplified their therapy by replacing protease inhibitors (PI) with efavirenz. In a large cohort study representative of clinical practice, we compared outcomes in patients who replaced PI with efavirenz (switchers), wi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7319d5634ae8abd517e66a501c29eca9
https://doi.org/10.1097/00002030-200202150-00009

Zobrazit plný text záznamu

Long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced HIV-infected children

Autor: Christoph, Rudin, Marcus, Burri, Yang, Shen, Richard, Rode, David, Nadal, S, Yerly

Publikováno v: Pediatric Infectious Disease Journal, Vol. 27, No 5 (2008) pp. 431-437

AIM: To evaluate the long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced, initially protease inhibitor (PI)-naive, human immunodeficiency virus (HIV)-1-infected children. METHODS: HIV-1-i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ed44aa9e81459e106d0166b94530dd2

Zobrazit plný text záznamu

Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study

Autor: Martin Rickenbach, Rainer Weber, Heiner C. Bucher, Pietro Vernazza, James Young, Enos Bernasconi, Philip E. Tarr, Hansjakob Furrer, Manuel Battegay, Bernard Hirschel

Publikováno v: Antiviral Therapy, Vol. 10, No 5 (2005) pp. 585-591
Europe PubMed Central
Scopus-Elsevier

Background Blood lipid abnormalities in patients on highly active antiretroviral therapy (HAART) have been associated with exposure to protease inhibitors (PIs), particularly ritonavir. First therapy with a non-nucleoside reverse transcriptase inhibi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6ca719ca506075f3a276f2bd0711ad5
https://archive-ouverte.unige.ch/unige:7713

Zobrazit plný text záznamu

Insulin resistance in HIV protease inhibitor-associated diabetes

Autor: Samuel Dagogo-Jack, Philippe A. Halban, Alan Bohrer, John Turk, Catherine Sigmund, Kevin E. Yarasheski, Pablo Tebas, Philip E. Cryer, William G. Powderly

Publikováno v: Journal of Acquired Immune Deficiency Syndromes, Vol. 21, No 3 (1999) pp. 209-216

BACKGROUND: Fasting hyperglycemia has been associated with HIV protease inhibitor (PI) therapy. OBJECTIVE: To determine whether absolute insulin deficiency or insulin resistance with relative insulin deficiency and an elevated body mass index (BMI) c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::490a3b2b3bb830d30c0826292032c10a
https://archive-ouverte.unige.ch/unige:9283

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání